Bruzzone P, Pretagostini R, Poli L, Rossi M, Berloco P B
Divisione Trapianti d'Organo, Dipartimento Paride Stefanini, Università di Roma La Sapienza, Rome, Italy.
Transplant Proc. 2005 Jul-Aug;37(6):2436-8. doi: 10.1016/j.transproceed.2005.06.015.
Kidney transplantation from living donors is widely performed all over the world. Living nephrectomy for transplantation has no direct advantage for the donor other than increased self-esteem, but at least remains an extremely safe procedure, with a worldwide overall mortality rate of 0.03%. This theoretical risk to the donor seems to be justified by the socioeconomic advantages and increased quality of life of the recipient, especially in selected cases, such as pediatric patients, when living donor kidney transplantation can be performed in a preuremic phase, avoiding the psychological and physical stress of dialysis, which in children is not well tolerated and cannot prevent retarded growth. According to the Ethical Council of the Transplantation Society, commercialism must be prevented, not only for ethical but also medical reasons. The risks are too high not only for the donors, but also for the recipients, as a consequence of poor donor screening and evaluation with consequent transmission of human immunodeficiency virus or other infectious agents, as well as inappropriate medical and surgical management of donors and also of recipients, who are often discharged too early. Most public or private insurance companies are considering kidney donation a safe procedure without long-term impairment and, therefore, do not increase the premium, whereas recipient insurance of course should cover hospital fees for the donors. "Rewarded gifting" or other financial incentives to compensate for the inconvenience and loss of income related to the donation are not advisable, at least in our opinion. Our center does not perform anonymous living organ donation or "cross-over" transplantation.
活体供肾移植在全球范围内广泛开展。供体肾切除术对供体而言,除了能增强自尊外并无直接益处,但至少仍是一种极其安全的手术,全球总体死亡率为0.03%。对供体的这种理论风险似乎因受体的社会经济优势和生活质量提高而合理,尤其是在特定情况下,如儿科患者,此时活体供肾移植可在尿毒症前期进行,避免透析带来的心理和身体压力,而儿童对透析耐受性差且透析无法防止生长发育迟缓。根据移植学会伦理委员会的意见,必须防止商业化,这不仅出于伦理原因,也出于医学原因。由于供体筛查和评估不当导致人类免疫缺陷病毒或其他传染源传播,以及供体和受体的医疗及手术管理不当(受体常过早出院),风险不仅对供体过高,对受体也过高。大多数公共或私人保险公司认为肾脏捐赠是一种安全的手术,不会造成长期损害,因此不会提高保费,而受体保险当然应涵盖供体的住院费用。至少在我们看来,“有偿馈赠”或其他经济激励措施来补偿捐赠带来的不便和收入损失是不可取的。我们中心不进行匿名活体器官捐赠或“交叉”移植。